Triage of women with atypical squamous cells of undetermined significance (ASC-US): Results of an Italian multicentric study

Gynecologic Oncology

Volumn 117, Issue 1, 2010, Pages 77-81

  Del Mistro, Annarosa ^a   Frayle Salamanca, Helena ^a   Trevisan, Rossana ^a   Matteucci, Mario ^b   Pinarello, Antonella ^c   Zambenedetti, Pamela ^d   Buoso, Rita ^e   Fantin, Gian Piero ^f   Zorzi, Manuel ^a   Minucci, Daria ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c ULSS 8   (Italy)

^d ULSS 13   (Italy)

^e Azienda ULSS 18   (Italy)

^f ULSS 7   (Italy)

Author keywords

Cervical cancer; HPV; Screening; Triage

Indexed keywords

DNA;

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER CELL; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA EXTRACTION; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN PAPILLOMA VIRUS TEST; ITALY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS TYPING; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 77949335543     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.01.003     Document Type: Article

References (25)

1. IARC Working Group. Human Papillomavirus. IARC Monographs on the evaluation of carcinogenic risk to humans, vol 90; Lyon 2007. International Agency for Research on Cancer.
2. Ronco G., and Giorgi Rossi P. New paradigms in cervical cancer prevention: opportunities and risks. BMC Womens Health 8 (2008 Dec 17) 23
3. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. Young N; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 16 (2002) 2114-2119
4. Castle P.E., Sideri M., Jeronimo J., Solomon D., and Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am. J. Obstet. Gynecol. 197 4 (2007) 356.e1-356.e6
5. Del Mistro A. ASC-US diagnosis and triage. Gynecol. Oncol. 107 (2007) S2-S4
6. Arbyn M., Buntinx F., et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J. Natl. Cancer Inst. 96 4 (2004) 280-293
7. Gatscha R.M., Abadi M., Babore S., Chhireng D., Miller M.J., and Saigo P.E. Smears diagnosed as ASCUS: interobserver variation and follow-up. Diagn. Cytopathol. 25 (2001) 138-140
8. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens: Part B. Biological agents. Lancet Oncol. 10 (2009) 321-322
9. Del Mistro A., Bertorelle R., Franzetti M., Cattelan A., Torrisi A., Giordani A., et al. Clinical evolution of papillomavirus-associated genital lesions in HIV-positive women and antiretroviral therapy. Clin. Infect. Dis. 38 (2004) 737-742
10. Nobre R.J., de Almeida L.P., and Martins T.C. Complete genotyping of mucosal human Papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J. Clin. Virol. 42 1 (2008) 13-21
11. Del Mistro A., Salamanca H.F., Trevisan R., Bertorelle R., Parenti A., Bonoldi E., et al. Human papillomavirus typing of invasive cervical cancers in Italy. Infect. Agent Cancer 1 (2006) 9
12. Bulkmans N., Berkhof J., Rozendaal L., van Kemenade F.J., Boeke A., Bulk S., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomized controlled implementation trial. Lancet 370 (2007) 1764-1772
13. Naucler P., Ryd W., Tornberg S., Strand A., Wadell G., Elfgren K., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N. Engl. J. Med. 357 (2007) 1589-1597
14. Kitchener H.C., Almonte M., Wheeler P., Desai M., Gilham C., Bailey A., et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br. J. Cancer 95 (2006) 56-61
15. Ronco G., Segnan N., Giorgi-Rossi P., Zappa M., Casadei G.P., Carozzi F., et al. Human Papillomavirus testing and liquid-based cytology in primary cervical screening: results at recruitment from the NTCC randomized controlled trial. JNCI 98 (2006) 765-774
16. Ronco G., Giorgi-Rossi P., Carozzi F., Confortini M., Dalla Palma P., Del Mistro A., et al. Results at recruitment from a randomized controlled trial comparing Human Papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. JNCI 100 (2008) 492-501
17. Solomon D., Schiffman M., and Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 93 (2001) 293-299
18. Arbyn M., Martin-Hirsch P., Buntinx F., Van Ranst M., Paraskevaidis E., and Dillner J. Triage of women with equivocal or low-grade cervical cytology: a meta-analysis of the HPV test positivity rate. J. Cell. Mol. Med. 13 4 (2009) 648-659
19. Ronco G., Cuzick J., Segnan N., Brezzi S., Carozzi F., Folicaldi S., et al. HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytology. Eur. J. Cancer 43 3 (2007) 476-480
20. Giovannelli L., Capra G., Lama A., Bustinto T., Genco A., Valenti F.M., et al. Atypical squamous cells of undetermined significance-favour reactive compared to atypical squamous cells of undetermined significance-favour dysplasia: association with cervical intraepithelial lesions and human papillomavirus infection. J. Clin. Virol. 33 (2005) 281-286
21. Clifford G.M., Smith J.S., Aguado T., and Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br. J. Cancer 89 (2003) 101-105
22. Porras C., Rodríguez A.C., Hildesheim A., Herrero R., González P., Wacholder S., et al. Human Papillomavirus types by age in cervical cancer precursors: predominance of Human Papillomavirus 16 in young women. Cancer Epidemiol. Biomarkers Prev. 18 3 (2009) 863-865
23. Castle P.E., Solomon D., Wheeler C.M., Gravitt P.E., Wacholder S., and Schiffman M. Human papillomavirus genotype specificity of hybrid capture 2. J. Clin. Microbiol. 46 8 (2008) 595-604
24. Castle P.E., Rodriguez A.C., Burk R.D., Herrero R., Wacholder S., Alfaro M., et al. Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ b2569 (2009) 339
25. Ronco G., Arbyn M., and Segnan N. Cervical screening according to age and HPV status. BMJ 339 (2009) b3005